Cancer lab will double HQ size

NeoGenomics isn't slowing down despite the threat of drastically lower government reimbursements for the cancer tests it performs.

The firm plans to more than double the size of its Fort Myers headquarters, CEO Douglas VanOort told analysts during a recent conference call to discuss the company's quarterly earnings.

“After the successful expansion and move of our laboratory facility in Irvine, [Calif.] last year, we are now engaged in an expansion of our largest laboratory in Fort Myers,” says VanOort, in a transcript posted on SeekingAlpha.com.